Contemporary HIV Treatment and Prevention 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: April 28, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Darcy Wooten, MD Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Daniel R. Kuritzkes, MD Released: March 25, 2022

Read expert faculty summaries on the latest data in first-line ART therapy in diverse patients to assist with individualized ART selection.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Princy N. Kumar, MD, FIDSA, MACP Released: April 1, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Gregory Huhn, MD, MPHTM Released: May 4, 2022

Read expert faculty members’ summaries of state-of-the-art switch strategies in virologically suppressed patients, including switching ART in the setting of resistance, considerations for long acting injectables, and switching ART prior to or during pregnancy.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Paul E. Sax, MD Released: May 6, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: May 27, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: September 23, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: May 31, 2022

Download slides to review expert insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, COVID-19 in PWH, and Monkeypox.

David A. Wohl, MD Released: September 23, 2022

Read expert nursing faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Download slides to review expert pharmacist insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: January 10, 2023

Download slides to review expert nurse insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: January 11, 2023

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake in adolescents.

Timothy J. Wilkin, MD, MPH Released: November 7, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake in the context of race.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for cisgender women.

Timothy J. Wilkin, MD, MPH Released: November 15, 2022

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for transgender women.

Listen to Timothy J. Wilkin, MD, MPH, discuss barriers to PrEP uptake for people who inject drugs.

Listen to Timothy J. Wilkin, MD, MPH, discuss solutions for expanding PrEP uptake.

Listen to Paul E. Sax, MD, discuss what’s new in long-acting injectables for HIV treatment.

Paul E. Sax, MD Released: November 14, 2022

Listen to Paul E. Sax, MD, discuss the latest recommendations and options for HIV pre-exposure prophylaxis.

Paul E. Sax, MD Released: November 14, 2022

Listen to Roger Bedimo, MD, MS, FACP, discuss key considerations for switching ART in virologically suppressed patients who are pregnant or trying to conceive.

Roger Bedimo, MD, MS, FACP Released: October 3, 2022

Listen to Timothy J. Wilkin, MD, MPH, provide a case-based overview of switching antiretroviral therapy in a person with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations.

Timothy J. Wilkin, MD, MPH Released: October 20, 2022

Learn about ART selection in treatment-naive PWH based on the latest guideline recommendations through case-based discussions by Princy N. Kumar, MD, FIDSA, MACP.

Princy N. Kumar, MD, FIDSA, MACP Released: December 29, 2022

Listen to this patient case from Princy N. Kumar MD, FIDSA, MACP, as she shares the latest data on weight gain after ART initiation.

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, and COVID-19 in PWH.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Allison Webel, PhD, RN Mitchell J. Wharton, PhD, RN, FNP-BC, CNS, ACRN Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: November 22, 2022 Expired: No longer available for credit

Hear from expert faculty members as they present nursing insights on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Jasjit Gill, BSPharm, PharmD Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 10, 2022 Expired: No longer available for credit

Listen to expert faculty as they discuss inequities in PrEP uptake in key populations, structural barriers to PrEP adoption, and solutions for expanding PrEP use.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Christopher B. Fox, MSN, RN, ANP-BC, AAHIVS Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 14, 2022 Expired: No longer available for credit

Hear from expert faculty members as they present some of the most clinically relevant new data presented at CROI 2022 and discuss how they will incorporate the data on prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure strategies into their own practices.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Gregory Huhn, MD, MPHTM Daniel R. Kuritzkes, MD Babafemi Taiwo, MBBS Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: June 17, 2022 Expired: No longer available for credit

Hear from expert faculty members as they present some of the most clinically relevant new data presented at AIDS 2022 and discuss how they will incorporate the data on prevention strategies, oral therapies, long-acting therapies, cure strategies, COVID-19, and monkeypox into their own practices.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Princy N. Kumar, MD, FIDSA, MACP Mary W. Montgomery, MD David A. Wohl, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: December 23, 2022 Expired: No longer available for credit

Major inequities in PrEP uptake, adherence, and persistence have been seen in Black and Hispanic/Latinx people, cisgender women, transgender women, adolescents, and people who inject drugs. Here’s how we can address them.

Neha Pandit, PharmD, AAHIVP, BCPS Released: December 2, 2022

We now have long-acting injectable options for both the treatment and prevention of HIV, with more to learn as we incorporate this exciting new paradigm. Here are my thoughts on key differences among available HIV prevention medications and the potential role of individual pharmacokinetic variability in the efficacy of long-acting options for prevention and treatment.

Melanie Nicol, PharmD, PhD Released: December 30, 2022

Finding an appropriate and effective therapeutic regimen for treatment-experienced people with HIV can be challenging. Read my summary of the current options available for managing these complex cases.

Rodrigo Burgos, PharmD, MPH Released: February 6, 2023